Infantile facioscapulohumeral muscular dystrophy with Coat's syndrome

S K Tamer1, S Jain1, S Hiran1

  • 1Department of Neurosciences, JLN Hospital and Research Centre, Bhilai - 490 006, Madhya Pradesh, India.

Neurology India
|March 8, 2018
PubMed

Insights

This case study presents an unusual presentation of facioscapulohumeral dystrophy (FSH) with early infantile onset and unique progressive features. The case highlights atypical calf hypertrophy, skeletal, and retinal changes, offering new insights into FSH disease progression.

Area of Science:

  • Neurology
  • Genetics
  • Ophthalmology

Background:

  • Facioscapulohumeral dystrophy (FSH) is a genetic myopathy typically presenting in adolescence or early adulthood.
  • The disease course is variable, often characterized by periods of stability or slow progression.

Purpose of the Study:

  • To present a rare case of facioscapulohumeral dystrophy (FSH) with atypical clinical manifestations.
  • To highlight unusual features including early-onset, relentless progression, and associated systemic findings.

Main Methods:

  • Case report detailing clinical history, physical examination, and diagnostic findings.
  • Review of relevant literature on facioscapulohumeral dystrophy and its variants.

Main Results:

  • The patient exhibited infantile onset of FSH, deviating from the typical second-decade onset.
  • Progressive muscular weakness without apparent arrest, calf hypertrophy, significant skeletal abnormalities, and Coat's disease-like retinal changes were observed.
  • These features represent a highly unusual constellation for FSH.

Conclusions:

  • This case underscores the phenotypic variability of facioscapulohumeral dystrophy (FSH).
  • Early-onset FSH with relentless progression and associated systemic findings, including retinal changes, requires careful diagnostic consideration and management strategies.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...